These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33045182)

  • 41. Assessing change in functional outcomes and quality of life in myogenic temporomandibular disorders undergoing botulinum toxin injection: A before and after comparison.
    Hosgor H; Coskunses FM; Altindis S
    J Stomatol Oral Maxillofac Surg; 2023 Sep; 124(4):101434. PubMed ID: 36914004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
    Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of topical vs injection treatment of cervical myofascial trigger points on headache symptoms in migraine patients: a retrospective analysis.
    Affaitati G; Costantini R; Tana C; Lapenna D; Schiavone C; Cipollone F; Giamberardino MA
    J Headache Pain; 2018 Nov; 19(1):104. PubMed ID: 30409108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platelet-Rich Plasma Intramuscular Injections - Antinociceptive Therapy in Myofascial Pain Within Masseter Muscles in Temporomandibular Disorders Patients: A Pilot Study.
    Nitecka-Buchta A; Walczynska-Dragon K; Kempa WM; Baron S
    Front Neurol; 2019; 10():250. PubMed ID: 30941095
    [No Abstract]   [Full Text] [Related]  

  • 45. Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A.
    Ferrante FM; Bearn L; Rothrock R; King L
    Anesthesiology; 2005 Aug; 103(2):377-83. PubMed ID: 16052120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia.
    Hong CZ; Hsueh TC
    Arch Phys Med Rehabil; 1996 Nov; 77(11):1161-6. PubMed ID: 8931529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulinum toxin A versus platelet rich plasma ultrasound-guided injection in the treatment of plantar fasciitis: A randomised controlled trial.
    Ruiz-Hernández IM; Gascó-Adrien J; Buen-Ruiz C; Perelló-Moreno L; Tornero-Prieto C; Barrantes-Delgado G; García-Gutiérrez M; Rapariz-González JM; Tejada-Gavela S
    Foot Ankle Surg; 2024 Feb; 30(2):117-122. PubMed ID: 37949704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in masticatory function after injection of botulinum toxin type A to masticatory muscles.
    Park HU; Kim BI; Kang SM; Kim ST; Choi JH; Ahn HJ
    J Oral Rehabil; 2013 Dec; 40(12):916-22. PubMed ID: 24237358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Botulinum toxin type A and myofascial pain syndrome: a retrospective study of 301 patients.
    Avendaño-Coy J; Gómez-Soriano J; Valencia M; Estrada J; Leal F; Ruiz-Campa R
    J Back Musculoskelet Rehabil; 2014; 27(4):485-92. PubMed ID: 24867895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intramuscular botulinum toxin injection additional to arthrocentesis in the management of temporomandibular joint pain.
    Ivask O; Leibur E; Akermann S; Tamme T; Voog-Oras Ü
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):e99-e106. PubMed ID: 27496577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of botulinum toxin therapy in treatment of myofascial pain.
    Chaurand J; Pacheco-Ruíz L; Orozco-Saldívar H; López-Valdés J
    J Oral Sci; 2017; 59(3):351-356. PubMed ID: 28904310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incobotulinum toxin type A for treatment of chronic myofascial pain.
    Chaurand J; Godínez-Victoria M; Tellez-Girón A; Facio-Umaña JA; Jimenez-Ponce F
    J Oral Sci; 2020 Dec; 63(1):37-40. PubMed ID: 33298638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Botulinum toxin type A and acupuncture for masticatory myofascial pain: a randomized clinical trial.
    DE LA Torre Canales G; Câmara-Souza MB; Poluha RL; Grillo CM; Conti PCR; Sousa MDLR; Rodrigues Garcia RCM; Rizzatti-Barbosa CM
    J Appl Oral Sci; 2021; 29():e20201035. PubMed ID: 34105695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum toxin type A for the treatment of head and neck chronic myofascial pain syndrome: A systematic review and meta-analysis.
    Khalifeh M; Mehta K; Varguise N; Suarez-Durall P; Enciso R
    J Am Dent Assoc; 2016 Dec; 147(12):959-973.e1. PubMed ID: 27737756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of patient satisfaction after botulinum toxin A injection for the management of masticatory myofascial pain and dysfunction - A pilot study.
    Meral SE; Tüz HH; Başlarlı Ö
    Cranio; 2021 Jan; 39(1):12-16. PubMed ID: 30600786
    [No Abstract]   [Full Text] [Related]  

  • 56. [The use of botulinum toxin type A in masseter muscle hypertrophy: long-term effects and lasting improvement].
    Aydil B; Başaran B; Unsaler S; Süoğlu Y
    Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):249-53. PubMed ID: 22991984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does myofascial and trigger point treatment reduce pain and analgesic intake in patients undergoing onabotulinumtoxinA injection due to chronic intractable migraine?
    Gandolfi M; Geroin C; Valè N; Marchioretto F; Turrina A; Dimitrova E; Tamburin S; Serina A; Castellazzi P; Meschieri A; Ricard F; Saltuari L; Picelli A; Smania N
    Eur J Phys Rehabil Med; 2018 Feb; 54(1):1-12. PubMed ID: 28750504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of Botulinum Toxin for Treatment of Symptomatic Pelvic Floor Myofascial Pain in Women: A Systematic Review and Meta-analysis.
    Meister MR; Brubaker A; Sutcliffe S; Lowder JL
    Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e152-e160. PubMed ID: 32301801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement.
    Kurtoglu C; Gur OH; Kurkcu M; Sertdemir Y; Guler-Uysal F; Uysal H
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1644-51. PubMed ID: 18634953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The immediate effects of atlanto-occipital joint manipulation and suboccipital muscle inhibition technique on active mouth opening and pressure pain sensitivity over latent myofascial trigger points in the masticatory muscles.
    Oliveira-Campelo NM; Rubens-Rebelatto J; Martí N-Vallejo FJ; Alburquerque-Sendí N F; Fernández-de-Las-Peñas C
    J Orthop Sports Phys Ther; 2010 May; 40(5):310-7. PubMed ID: 20436241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.